www.fdanews.com/articles/142352-pfizer-wins-fda-panel-39-s-backing-for-kidney-cancer-treatment
Pfizer Wins FDA Panel's Backing for Kidney-Cancer Treatment
December 8, 2011
Pfizer Inc., the world's biggest drugmaker, won a U.S. panel's backing for an experimental medicine for advanced kidney cancer in patients who have failed prior treatments.
Businessweek
Businessweek